coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Deal & Sandwich PCN, Dover · Health Inequalities Profile

    PCN U25255 · NHS Kent and Medway Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,728

    Registered population

    53.0% aged 18–64

    30.6%

    Aged 65+

    ICB 19.9% · England 17.9%

    3.1%

    Ethnic minority (non-White)

    1.1% Asian · England 9.6%

    2.9%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~1,376

    Core20 residents (est.)

    Resident basis; registered basis ~1,461 · see page 3

    10,087

    Hypertension register

    +7.60% in 3 yrs · England +5.60%

    492

    SMI register

    38.6% of Dover's

    1,606

    COPD register

    Reviews +3.72% in 3 yrs

    Forecast to 2030

    12,222

    Hypertension patients, 2030

    +2,135 on today

    72.0%

    QRISK ≥20% on statins, 2030

    +4.63pp over 3 yrs

    7.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    60.4%
    Asthma reviews trail England alongside high prescribing.

    Annual asthma reviews reach 60.4% (England 65.7%, Dover 62.0%), leaving about 1,300 of 3,320 patients unreviewed alongside 2,035 items per 1,000 aged 5-19.

    61.5%
    QRISK lipid therapy lags with higher unit cost.

    Lipid-lowering therapy for QRISK ≥ 20% is 61.5% (England 63.6%), while 88,342 lipid-modifying items cost £2.40 each, or £47,705 more than England's £1.86 rate.

    79.7%
    Heart failure reviews exceed local and national rates.

    Annual heart failure reviews reach 79.7% (England 78.5%, Dover 71.2%), rising +19.4% over three years (England +8.7%, Dover -7.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 30.6% aged 65 and over, an older population could increase local care demand

    Across 48,728 registered patients, 30.6% (14,937) are aged 65+, well above Dover (24.2%), NHS Kent and Medway ICB (19.9%) and England (17.9%). Working-age adults (18-64) make up 53.0% (25,816), below Dover (56.8%), the ICB (59.5%) and England (62.7%), while children (0-17) represent 16.4% (7,975). List size is projected to grow +3.6% by 2030 (Dover +5.3%, ICB +6.0%, England +2.3%; unverified methodology). Census resident data shows 96.8% White (Dover 94.9%, ICB 88.6%, England 81.1%) and 1.1% Asian / Asian British (Dover 2.1%, ICB 4.7%, England 9.6%), with an estimated 3.1% non-White ethnic minority share.

    Age profile

    0–1716.4%
    18–6453.0%
    65+30.6%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White96.8%
    Mixed1.3%
    Asian1.1%
    Other0.4%
    Black0.3%

    Older people · falls rows are Dover local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Dover LA)1,5572,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.9%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Dover LA)8869819552024/25
    Falls deaths, all ages, per 100,000 (Dover LA)25.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Only 2.9% of registered patients live in Core20 areas, unevenly distributed across practices

    Core20 patients—living in England's most deprived 20% of areas—comprise 2.9% of registered patients, below Dover (22.9%), NHS Kent and Medway ICB (17.1%), and England (21.0%). Practice estimates sum to 1,461 patients, while resident decile estimates total 1,376, reflecting differing population bases. Distribution is uneven: The New Golf Road Surgery has the highest share (6.3%, 166 estimated patients), whereas Balmoral Surgery holds the largest volume (5.1%, 590 estimated patients); Sandwich Medical Practice records 0.0%. Outreach should balance volume-led clinical recall with targeted community engagement.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    New Golf Road6.3% · 166 patients
    Balmoral5.1% · 590 patients
    St Richards Road3.4% · 347 patients
    Cedars3.1% · 358 patients
    Sandwich Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    492

    SMI register

    1.00% recorded prevalence

    332

    Learning disability register

    0.68% recorded prevalence

    26

    Care homes, 610 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Dover, Census 2021

    Recorded registers include 492 patients with severe mental illness (1.0% vs Dover 1.1%, ICB 0.9%, England 1.0%) and 332 with learning disabilities (0.7% vs Dover 0.8%, ICB 0.6%, England 0.6%). The catchment contains 26 care homes with 610 beds. Dover's 10.3% unpaid care rate and 8 rough sleepers (2025) cannot be extrapolated to PCN lists.

    Severe mental illness: physical health checks

    Across 492 patients on the SMI register (1.0%), 84.5% received a blood pressure check (England 83.4%), but BMI recording reached 78.4% (England 82.1%), while alcohol recording was 80.7% (England 81.8%). Missing elements cannot imply completed checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,087

    Hypertension register

    +7.60%

    Register growth, 3 yrs

    Dover +6.06% · England +5.60%

    +1.43pp

    BP control, under 80

    ≤140/90 · −0.05pp aged 80+

    +2,135

    More patients by 2030

    Forecast 12,222 (23.83%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 20.6% (10,087 patients), above Dover (18.3%), NHS Kent and Medway ICB (16.2%) and England (15.2%), consistent with an older demographic where 30.6% are aged 65+. For patients aged 80 and over, blood pressure control to <= 150/90 mmHg is 78.0%, below Dover (78.7%), the ICB (78.3%) and England (81.2%), with three-year change trailing at -0.1% (England +2.2%). Denominators include personalised care adjustments, and crude prevalence is not age-adjusted. Lower blood pressure control among older patients than England may indicate scope to review recall and titration protocols for hypertensive patients aged 80 and over.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 61.5% receive lipid-lowering therapy, below Dover (62.6%) and England (63.6%), but above the ICB (61.4%). Statin coverage in diabetes aged 40+ without cardiovascular disease is 73.1% (England 73.2%). Lower high-risk lipid coverage than England may suggest scope for primary prevention recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202688,342£2.40£1.90£1.86£212,021
    Cardiovascular (all), 2025117,581£4.19£3.57£3.33£492,664

    In 2026, lipid-modifying drugs cost £2.40 per item across 88,342 items, exceeding Dover (£2.27), NHS Kent and Medway ICB (£1.90) and England (£1.86). The PCN spends £47,705 more than at England's unit cost. Higher unit costs than benchmarks may indicate scope to review lipid-modifying formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +3.82%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +7.41%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.1% (3,320 patients; England 6.6%) and COPD prevalence is 3.3% (1,606 patients; England 1.9%). Annual asthma reviews reached 60.4% (England 65.7%), leaving about 1,300 unreviewed patients (1,315 by calculation), while COPD reviews reached 74.1% (England 76.4%). Paediatric asthma prescribing reached 2,035 items per 1,000 aged 5–19 (England 1,488), yet second-hand smoke recording for ages 6–19 reached 71.0% (254 patients; England 78.8%). High prescribing alongside lower review rates could reflect reliance on reliever therapy, which local prescribing audit would test.

    Cancer register and children's immunisation

    Crude cancer prevalence is 6.4% (3,118 patients; England 3.8%), which is consistent with an older age profile (30.6% aged 65+, England 17.9%). Childhood immunisation exceeds benchmarks at 24 months (MMR1 96.1%, 6-in-1 98.7%), but age-5 boosters trail the 95.0% target: MMR2 reaches 93.1% (a 1.9 pp drop from MMR1) and the 4-in-1 booster is 90.1% (below target by 4.9 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.5%

    England 91.0%

    6-in-1 complete primary course at 24 months98.7%

    England 92.2%

    MMR dose 1 at 24 months96.1%

    England 88.3%

    MMR dose 2 at age 593.1%

    England 82.8%

    4-in-1 pre-school booster at age 590.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of cancers with a known stage in NHS Kent and Medway ICB (4,661 of 8,384) were diagnosed at stage 1 or 2, in line with England (55.3%) but below the 75.0% national ambition by 19.4 pp. Reaching 75.0% would require an estimated 1,627 extra early diagnoses across the ICB. Cancer staging was not captured at PCN level and excludes unstageable cases (63.6% known-stage coverage, 8,384 of 13,189). In DEAL & SANDWICH PCN, breast screening reaches 72.1%, while The New Golf Road Surgery records 66.1% (England 69.9%). Lower practice screening coverage may delay presentation, reinforcing the need to review local uptake alongside wider system pathway improvements.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Kent Hospitals University NHS Foundation Trust achieved 70.0% against the 85.0% 62-day standard, behind the ICB (75.9%) and England (71.2%), while East Sussex Healthcare NHS Trust achieved 67.0%. For the 28-day faster diagnosis standard (75.0%), the trust reached 71.3% (ICB 76.8%, England 79.3%), though it met the 31-day standard at 96.7% (standard 96.0%). For diagnostics in July 2026, 63.0% of non-obstetric ultrasound and 47.6% of MRI patients waited 6+ weeks at the trust (England 19.6% and 21.4%). Provider waiting times and diagnostic backlogs describe system capacity rather than PCN performance, but require ongoing clinical safety-netting.

    Pathways within standard (%)East KentEast Sussex HealthcareMid and South EssexKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2884.2067.4576.7879.32
    31-day treatment (96%)96.6798.1981.8895.8492.50
    62-day referral to treatment (85%)70.0167.0450.2575.9371.16
    Diagnostic waits over 6 weeks (%)East KentEast Sussex HealthcareMid and South EssexEngland
    MRI47.586.4823.3521.40
    CT37.450.486.079.92
    Echocardiography14.1721.9465.0528.48
    Colonoscopy9.580.7464.0930.83
    Gastroscopy22.160.3159.7629.02
    All 15 DM01 tests48.385.2741.5423.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In the community services dataset for June 2026 (provisional), adults aged 65+ accounted for 65.8% of contacts among Dover local authority residents (138,250 of 210,170 total contacts). Community service activity is captured solely for borough residents and was not captured for DEAL & SANDWICH PCN or individual practices. Community health activity in Dover is heavily concentrated among older residents, indicating substantial local community support needs.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF vaccination achievement spans 24.6 pp, from 53.3% at The Cedars Surgery to 77.9% at St Richards Road Surgery. Overall QOF achievement ranges from 88.7% at Sandwich Medical Practice to 97.3% at Balmoral Surgery. Personalised care adjustment rates across all domains vary from 5.9% at Sandwich Medical Practice to 16.0% at Balmoral Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    New Golf Road1346.387.0%73.3%90.1%
    The Cedars Surgery1033.156.0%77.9%80.9%
    Sandwich Medical930.042.2%63.6%77.3%
    Balmoral Surgery1145.144.3%68.2%74.5%
    St Richards Road1183.444.9%67.7%73.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNDoverAssetPCNDover
    Care homes (catchment)26 (610 beds)n/aSchools (catchment)56n/a
    Children's centres27Places of worship70106
    Libraries45Food banks (VCS)n/a2
    Homelessness support (VCS)n/a1Day centres (VCS)14
    Carers support groups (VCS)14Primary schools (LA maintained)919
    Primary academies1121Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Asthma reviews reach 60.4% (Dover 62.0%, England 65.7%) across 3,320 patients, leaving 1,315 (about 1,300) unreviewed, while age 5–19 prescribing is 2,035 per 1,000 (England 1,488). For discussion: practices could run structured asthma recall combining annual reviews, second-hand smoke recording (71.0% vs 78.8% England) and inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Lipid therapy recall and formulary review

    QRISK ≥ 20% lipid therapy is 61.5% (Dover 62.6%, England 63.6%) and diabetes statins fell 1.5% (England +2.1%), while lipid-modifying drugs cost £2.40 per item (England £1.86), or £47,705 more across 88,342 items. For discussion: clinical pharmacists could combine high-risk lipid and diabetes statin recall with a lipid-modifying formulary review. Moderate effort to run.

    Option 3

    Hypertension control audit for aged 80+

    Across 10,087 hypertension patients (20.6%; England 15.2%), aged 80+ blood pressure control is 78.0% (Dover 78.7%, England 81.2%), and three-year change fell 0.1% (England +2.2%). For discussion: practices could audit hypertensive patients aged 80+ above 150/90 mmHg or missing checks (89.1% vs 90.0% England), aligning care-home monitoring. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory older adult care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Systematic SMI physical health checks (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertensive patient recall audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall (p7)Breast screening coverage: aged 53 to 70 years old—Practice
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Lipid therapy recall and formulary review (p12)Cost per item for Lipid-regulating drugs 2026 · Count of Items prescribed for Lipid-regulating drugs 2026 · Patients with QRISK ≥ 20% treated with lipid lowering therapy—PCN
    Option 3 · Hypertension control audit for aged 80+ (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15